- A combination of factors prompted some fresh selling around USD/CAD on Tuesday.
- Dovish Fed expectations, COVID-19 vaccine optimism weighed on the safe-haven USD.
- Positive oil prices underpinned the loonie and contributed to the intraday selling bias.
The USD/CAD pair traded with a negative bias through the early European session and was last seen flirting with a strong horizontal support, around the 1.3045-40 region.
Following the previous day's good two-way price swings, the pair met with some fresh supply on Tuesday and was being pressured by a combination of factors. The US dollar struggled to capitalize on its overnight goodish rebound that came following the release of upbeat US PMI prints for November. Apart from this, a positive tone around crude oil prices underpinned the commodity-linked loonie and exerted some pressure on the USD/CAD pair.
The greenback remained depressed on the back of growing market speculations that the Fed might ease monetary policy in December amid concerns about the economic fallout from the continuous surge in new coronavirus cases. Adding to this, the latest optimism over a potential early rollout of COVID-19 vaccines remained supportive of the prevalent risk-on environment. This added to the selling bias surrounding the safe-haven greenback.
Meanwhile, additional reports of successful COVID-19 vaccine trials revived hopes for a speedy global economic recovery and a pickup in energy demand. It is worth recalling that AstraZeneca said on Monday its COVID-19 vaccine was 70% to 90% effective in pivotal trials. This, in turn, pushed WTI crude oil prices to the highest level since March and benefitted the Canadian dollar, which further contributed to the USD/CAD pair's intraday slide.
From a technical perspective, sustained weakness below the 1.3040 support zone will be seen as a fresh trigger for bearish traders and turn the USD/CAD pair vulnerable to break below the key 1.3000 psychological mark. The downward trajectory could further get extended towards monthly swing lows, around the 1.2930-25 region.
Market participants now look forward to the US economic docket, featuring the releases of the Conference Board's Consumer Confidence Index and Richmond Manufacturing Index. The data, along with the broader market risk sentiment, might influence the USD price dynamics and assist traders to grab some short-term opportunities.
Technical levels to watch
|Today last price||1.3044|
|Today Daily Change||-0.0037|
|Today Daily Change %||-0.28|
|Today daily open||1.3081|
|Previous Daily High||1.3112|
|Previous Daily Low||1.3046|
|Previous Weekly High||1.3142|
|Previous Weekly Low||1.3034|
|Previous Monthly High||1.339|
|Previous Monthly Low||1.3081|
|Daily Fibonacci 38.2%||1.3071|
|Daily Fibonacci 61.8%||1.3087|
|Daily Pivot Point S1||1.3047|
|Daily Pivot Point S2||1.3013|
|Daily Pivot Point S3||1.298|
|Daily Pivot Point R1||1.3114|
|Daily Pivot Point R2||1.3147|
|Daily Pivot Point R3||1.3181|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.